Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
5,467,783
-
Shares change
-
+153,258
-
Total reported value, excl. options
-
$359,359,917
-
Value change
-
+$8,463,665
-
Number of buys
-
64
-
Number of sells
-
-48
-
Price
-
$65.72
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2024
173 filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q4 2024.
ISHARES TR - U.S. PHARMA ETF (IHE) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,467,783 shares
.
Largest 10 shareholders include Fisher Asset Management, LLC (3,226,694 shares), MORGAN STANLEY (380,621 shares), JPMORGAN CHASE & CO (188,567 shares), BANK OF AMERICA CORP /DE/ (164,218 shares), Royal Bank of Canada (101,659 shares), GOLDMAN SACHS GROUP INC (100,000 shares), BROWN ADVISORY INC (91,967 shares), LPL Financial LLC (81,188 shares), RAYMOND JAMES FINANCIAL INC (68,052 shares), and TWO SIGMA INVESTMENTS, LP (67,400 shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.